CaliPharms Pivots Into Amazon’s Last Mile Delivery

CaliPharms, Inc. (OTCPink: KGET),  publicly trading under the OTC Markets symbol "KGET" pivots its business model into Last Mile Delivery.

In CaliPharms search for an acquisition within the Cannabis distribution and delivery arena, an acquisition opportunity in the “Last Mile Delivery” space was recently presented to the company. The proposed acquisition is a fully operational last mile delivery business that has a service agreement with Amazon to delivery packages in the San Francisco Bay area, Oakland, and San Jose. 

Since 2016, the acquisition target company  has delivered 15 Million small to medium sized packages daily and last year recorded a $16.2 Million in revenue. In 2016, the target company began its’ last mile delivery customer with only five employees and in less than two years have grown its’ driver and administrative personnel to over 300 full time and part time employees. The target company has leveraged the increased demand for e-commerce delivery and is now considered one of the key courier company with its’ Fortune 50 customer in the San Francisco and East Bay area.

The target company continues to build partnerships and business relationship with national organizations in the transportation, fleet management, and staffing agencies.

KGET President and CEO Bo Linton stated, “This potential acquisition is the best opportunity ever presented to KGET. There is a huge future in global logistics in the last mile delivery market. If you live in the San Francisco Bay area and ordered something on Amazon Prime, there is a pretty good chance this company delivered it to you. The target company is an amazing business and the team of people running it are high caliber successful and driven people. The kind of people that make company's successful. This is great news for our shareholders.”

About CaliPharms, Inc. 

CaliPharms Inc., trading under the symbol (KGET) which trades under its former name Kleangas Energy Technologies, Inc. is a development stage business. The Company currently is focused on an acquisition within the Last Mile Delivery sector.

Safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as CaliPharms or KGET or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Investment into a microcap company is a high risk investment and it should only be considered if you are able to afford a total loss of the investment. 

Company Contact: 

CaliPharms, Inc. (KGET)

www.CaliPharmsInc.com

facebook.com/CaliPharms

twitter.com/CaliPharms

Telephone 1-949-800-6645

Email: info@CaliPharmsInc.com